Name: | Description: | Size: | Format: | |
---|---|---|---|---|
1.73 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms of cancer treatment, and P53 protein is one of the key molecules determining how a cell responds to radiotherapy. The aim of this study was to determine the therapeutic efficacy of iodine-131 in three human HCC cell lines.
Description
Keywords
Carcinoma Hepatocelular Proteína Supressora de Tumor p53
Citation
Clin Mol Hepatol. 2015 Sep;21(3):257-67.